Eli Lilly Aktie

648,80 EUR -8,90 EUR -1,35 %

10:19:00

XETRA

734,00 USD -0,63 USD -0,09 %

nachbörslich01:05:20

BTT

Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!

JETZT LOSLEGEN

Du hast schon ein ZERO-Konto? Direkt handeln bei ZERO!Bei einem anderen Broker handeln Smartphone

Marktkap.613,60 Mrd. EUR

KGV65,91Div. Rendite0,67%

WKN858560

ISINUS5324571083

SymbolLLY

Eli Lilly Aktien News

Sortieren:Datum Meistgelesen

27.09.24finanzen.netKursentwicklung

NYSE-Handel: S&P 500 beginnt Freitagssitzung mit Gewinnen

27.09.24MotleyFoolPrediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason

26.09.24ZacksEli Lilly (LLY) Stock Declines While Market Improves: Some Information for Investors

26.09.24BenzingaEli Lilly Stock Soars In 2024 On Weight Loss Drug Success, Now The Company Wants Medical Records Of Copycat Treatments

25.09.24BenzingaEli Lilly Unusual Options Activity

25.09.24ZacksEli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan

25.09.24BenzingaEli Lilly Touts Results Of EU-Approved Dermatitis Treatment, Shows Sustained Disease Control For Up To Three Years

25.09.24PR NewswireNew data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis

25.09.24EN, Eli LillyNew data show Lilly's EBGLYSS™ (lebrikizumab-lbkz) provided sustained disease control for up to three years in more than 80% of adults and adolescents with moderate-to-severe atopic dermatitis

24.09.24Benzinga$1000 Invested In Eli Lilly 20 Years Ago Would Be Worth This Much Today

24.09.24finanzen.netRentable Eli Lilly-Anlage?

S&P 500-Papier Eli Lilly-Aktie: So viel hätten Anleger mit einem Investment in Eli Lilly von vor 3 Jahren verdient

24.09.24EN, Eli LillyLilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's Disease

24.09.24PR NewswireLilly's Kisunla™ (donanemab-azbt) Approved in Japan for the Treatment of Early Symptomatic Alzheimer's Disease

23.09.24BenzingaSpotlight on Eli Lilly: Analyzing the Surge in Options Activity

21.09.24MotleyFoolPrediction: This Is What Eli Lilly Stock Will Do Next (Hint: It's Not a Stock Split)

21.09.24MotleyFoolWhy Novo Nordisk Stock Fell While Eli Lilly and Viking Therapeutics Bumped Higher Today

20.09.24BenzingaIn-Depth Analysis: Eli Lilly Versus Competitors In Pharmaceuticals Industry

20.09.24finanzen.netIndex im Blick

Schwacher Handel in New York: S&P 500 schwächelt zum Start des Freitagshandels

20.09.24BenzingaEli Lilly Fights $183M Medicaid Fraud Judgment, Cites Reasonable Interpretation Of Medicaid Rules

17.09.24ZacksEli Lilly Stock Up 21% in 6 Months: Time to Add to Your Portfolio?

17.09.24BenzingaUnpacking the Latest Options Trading Trends in Eli Lilly

17.09.24finanzen.netMarktbericht

Pluszeichen in New York: S&P 500 zum Handelsstart mit positivem Vorzeichen

17.09.24finanzen.netLukrativer Eli Lilly-Einstieg?

S&P 500-Papier Eli Lilly-Aktie: So viel Gewinn hätte ein Investment in Eli Lilly von vor einem Jahr abgeworfen

17.09.24ZacksIs Most-Watched Stock Eli Lilly and Company (LLY) Worth Betting on Now?

16.09.24BenzingaEli Lilly Scores FDA Approval For Eczema Treatment Ebglyss

13.09.24PR NewswireFDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis

13.09.24EN, Eli LillyFDA Approves Lilly's EBGLYSS™ (lebrikizumab-lbkz) for Adults and Children 12 Years and Older with Moderate-to-Severe Atopic Dermatitis

13.09.24MotleyFool6 Incredible Reasons to Invest in Eli Lilly

13.09.24dpa-afxAbnehmspritze Liraglutid mindert Übergewicht bei Kindern

12.09.24BenzingaEli Lilly Pumps $800M Into Irish Operations To Meet Skyrocketing Demand For Mounjaro, Zepbound

12.09.24BenzingaUnpacking the Latest Options Trading Trends in Eli Lilly

12.09.24MotleyFoolForget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now

12.09.24EN, Eli LillyLilly expands manufacturing footprint in Ireland with $1.8 billion investment

12.09.24PR NewswireLilly expands manufacturing footprint in Ireland with $1.8 billion investment

12.09.24ZacksEli Lilly and Hertz Global have been highlighted as Zacks Bull and Bear of the Day

12.09.24ZacksBull of the Day: Eli Lilly (LLY)

11.09.24MotleyFoolForget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound)

10.09.24BenzingaHere's How Much You Would Have Made Owning Eli Lilly Stock In The Last 20 Years

10.09.24PR NewswireWith once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes

10.09.24EN, Eli LillyWith once-a-week dosing, insulin efsitora alfa delivers similar A1C reduction compared to daily insulin in adults with type 1 diabetes

Eli Lilly News

Eli Lilly News: auf dieser Seite finden Sie alle Eli Lilly News und Nachrichten zur Eli Lilly Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Eli Lilly News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Eli Lilly News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.